Previous Speakers from the 2018 Event

Jeff Knight, Vice President, Clinical Operations, Clinical Outsourcing & Project Management, Halozyme Therapeutics

Lei Zhang, Vice President, Global Clinical Development and Operations, Zensun USA

James Wabby, Executive Director, Regulatory Affairs – Device/Combination Products, Allergan

Dov Gal, Vice President Regulatory and Clinical Affairs and Quality Assurance, ClearFlow

Rod Saponjic, Vice President, Global Development Operations, Greenwich Biosciences

Harri Jarvelainen, COO, DrugCendR

Mary Syto, Director, Clinical Operations, Celgene

Diane Fortune, Director, Development Outsourcing and Contracts, Vir Biotechnology

Ramani A. Aiyer, Executive Vice-President, Therabiol

Brian J. Byrnes, Senior Director, Clinical Projects, La Jolla Pharmaceutical Company

Nagesh Uppuluri, Senior Director. Global Medical Affairs, Medtronic

Brian Dempster, Director, Clinical Operations, Vital Therapies

Ken Wilson, Director, Sourcing Operations, Pfizer

Rosh Vora, VP, Clinical Affairs, PhysioCue

Mark Daniels, Director, Clinical Operations, Dauntless Pharmaceuticals

Raj Nihalani, Chief Technology & Business Development Officer, Reshape Life Sciences

Kenneth Kleinhenz, VP, Regulatory Affairs and Quality Assurance, Avelas Biosciences

Jacqueline Blem, Director, Clinical Operations, Triphase Accelerator

Andreza Oliveira, Director of Clinical Operations, Evofem Biosciences

Peter Stiegler, Senior Director Clinical Affairs, Progenity

Roberta Alton, Director, Clinical Operations, Halozyme Therapeutics

Joseph Djan, Director, Clinical Operations, Dart Neuroscience